标题
A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians
作者
关键词
-
出版物
Dermatology and Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-11-02
DOI
10.1007/s13555-022-00840-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pathophysiology of Generalized Pustular Psoriasis
- (2022) Slaheddine Marrakchi et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- A Multi-Center, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study Evaluating Efficacy and Safety of Vunakizumab in Patients with Moderate-to-Severe Plaque Psoriasis
- (2022) Chunlei Zhang et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology
- (2022) Debra Tompson et al. PHARMACEUTICAL RESEARCH
- Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
- (2022) Laida Elberdín et al. Dermatology and Therapy
- A Scoping Review on Use of Drugs Targeting the JAK/STAT Pathway in Psoriasis
- (2022) Francisco Gómez-García et al. Frontiers in Medicine
- Tapinarof Cream 1%: First Approval
- (2022) Susan J. Keam DRUGS
- 317 Characterization of pharmacokinetics, pharmacodynamics, tolerability and clinical activity in phase I studies of the novel allosteric tyrosine kinase 2 (TYK2) inhibitor NDI-034858
- (2022) E.A. Gangolli et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Switches between biologics in patients with moderate‐to‐severe psoriasis: results from the French cohort PSOBIOTEQ
- (2022) R. Curmin et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data
- (2022) Pnina Fishman MOLECULES
- 33226 Analysis of histologic and molecular improvement in moderate-to-severe psoriasis: Results from a phase 1b trial of the novel allosteric Tyk2 inhibitor NTX-973
- (2022) Joshua J. McElwee et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study
- (2021) Ulrich Mrowietz et al. Dermatology and Therapy
- Signaling of multiple IL‐17 family cytokines through IL‐17RA drive psoriasis‐related inflammatory pathways
- (2021) M.A.X. Tollenaere et al. BRITISH JOURNAL OF DERMATOLOGY
- An update on genetic basis of generalized pustular psoriasis (Review)
- (2021) Jiahong Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- POS1043 NETAKIMAB REDUCES PSORIATIC ARTHRITIS ACTIVITY IN PATIENTS WITH OR WITHOUT AXIAL DISEASE: SUBANALYSIS OF THE PATERA STUDY
- (2021) T. Korotaeva et al. ANNALS OF THE RHEUMATIC DISEASES
- Retinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases – where are we presently?
- (2021) Christian Gege Expert Opinion on Drug Discovery
- Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity
- (2021) Dominik Samotij et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772
- (2021) Debra J. Tompson et al. PHARMACEUTICAL RESEARCH
- Role of Janus Kinase Inhibitors in Therapy of Psoriasis
- (2021) Sylwia Słuczanowska-Głąbowska et al. Journal of Clinical Medicine
- Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial
- (2021) Luís Puig et al. Dermatology and Therapy
- Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors
- (2021) Anjaneya Chimalakonda et al. Dermatology and Therapy
- New Topical Therapies for Psoriasis
- (2021) Ana Maria Lé et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Trial of Spesolimab for Generalized Pustular Psoriasis
- (2021) Hervé Bachelez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis
- (2021) Mark G. Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms
- (2021) Liu Liu et al. Frontiers in Immunology
- Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation
- (2021) Nieves Fernández-Gallego et al. Cells
- Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases
- (2021) Maddalena Napolitano et al. Cells
- A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis
- (2021) Robert Bissonnette et al. Dermatology and Therapy
- Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments
- (2020) Magdalena Misiak-Galazka et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation
- (2020) Xiaoru Duan et al. Cell Death & Disease
- IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
- (2020) Esther von Stebut et al. Frontiers in Immunology
- Response to inhibition of receptor‐interacting protein kinase 1 (RIPK1) in active plaque psoriasis: a randomized placebo‐controlled study
- (2020) Kathleen Weisel et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
- (2020) April W. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trial of Roflumilast Cream for Chronic Plaque Psoriasis
- (2020) Mark G. Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
- (2020) Kevin Yang et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis
- (2020) Li Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
- (2020) Robert Croop et al. LANCET
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate the Tolerance, Pharmacokinetics of Jaktinib, a New Selective Janus Kinase Inhibitor in Healthy Chinese Volunteers
- (2020) Jingrui Liu et al. Frontiers in Pharmacology
- Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis
- (2019) Erica D. Dommasch et al. JAMA Dermatology
- State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis
- (2019) Paolo Gisondi et al. CURRENT OPINION IN PHARMACOLOGY
- Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: a double-blind, randomized, vehicle-controlled trial
- (2019) Peter W. Hashim et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An update on generalized pustular psoriasis
- (2019) Melinda J. Gooderham et al. Expert Review of Clinical Immunology
- Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment
- (2018) Tom C. Chan et al. Therapeutic Advances in Chronic Disease
- Prevalence and incidence of psoriasis and psoriatic arthritis
- (2018) Philipp Sewerin et al. ANNALS OF THE RHEUMATIC DISEASES
- The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
- (2018) Andrew Blauvelt et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
- (2018) Jason E. Hawkes et al. JOURNAL OF IMMUNOLOGY
- Adherence and resource use among psoriasis patients treated with biologics
- (2018) Joseph S. Aleshaki et al. Expert Review of Pharmacoeconomics & Outcomes Research
- The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
- (2018) Nicolo Costantino Brembilla et al. Frontiers in Immunology
- Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
- (2018) Heng Li et al. Frontiers in Pharmacology
- Psoriasis pathogenesis and the development of novel targeted immune therapies
- (2017) Jason E. Hawkes et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
- (2017) Andrew Johnston et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease
- (2017) Megan Hohenberger et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
- (2017) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Psoriasis and comorbid diseases
- (2017) Junko Takeshita et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis
- (2017) G. Girolomoni et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis
- (2016) Mohn’d AbuHilal et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis
- (2016) L. Puig et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- PASI90 response: the new standard in therapeutic efficacy for psoriasis
- (2014) L. Puig JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
- (2014) Leeyen Hsu et al. Journal of Immunology Research
- Cyclic AMP: a selective modulator of NF-κB action
- (2011) Sarah Gerlo et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial
- (2011) M. David et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The Structure of Interleukin-23 Reveals the Molecular Basis of p40 Subunit Sharing with Interleukin-12
- (2008) Patrick J. Lupardus et al. JOURNAL OF MOLECULAR BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started